Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses.

Human influenza viruses cause annual epidemics due to antigenic drifts in the hemagglutinin protein. Five antigenic sites in the influenza H3 hemagglutinin protein have been proposed and 131 amino acid positions have been identified in the five antigenic sites. A previous study had documented that a model based on the 131 positions in the five antigenic sites could moderately predict antigenic variants of influenza A/H3N2 viruses (agreement=83%). In this study, prediction models combining serology, bioinformatics and statistics were developed to predict antigenic variants of influenza A/H3N2 viruses. Amino acid sequences of hemagglutinin protein of 45 A/H3N2 viruses isolated during 1971-2002 and 181 pairwise antigenic distances determined by antibody cross-reactivity among the 45 viruses were analyzed as training dataset. In addition, 57 pairwise antigenic distances from 12 A/H3N2 viruses isolated during 1999-2004 were used as validation dataset. Multivariate regression models were employed to identify potential immunodominant positions and predict antigenic variants. Seventeen amino acid positions were identified as potential immunodominant positions in the training dataset. Prediction models based on the potential immunodominant positions have improved performance on predicting antigenic variants in the training (agreement=91%) and validation (agreement=93%) datasets. The model could be readily integrated to the global influenza surveillance system.

[1]  Hong Jin,et al.  Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. , 2005, Virology.

[2]  D. Jackson,et al.  Immune response of human volunteers and animals to vaccination with egg-grown influenza A (H1N1) virus is influenced by three amino acid substitutions in the haemagglutinin molecule. , 1993, Vaccine.

[3]  J Goodman,et al.  The value of a database in surveillance and vaccine selection , 2001 .

[4]  Chin-fen Yang,et al.  Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains. , 2003, The Journal of infectious diseases.

[5]  R. Webster,et al.  A DNA transfection system for generation of influenza A virus from eight plasmids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Oxford,et al.  Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. , 1989, Virology.

[7]  I. Wilson,et al.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation , 1981, Nature.

[8]  L. Simonsen,et al.  Surveillance and impact of influenza in the United States. , 1999, Vaccine.

[9]  A. Lapedes,et al.  Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.

[10]  A. García-Sastre,et al.  Rescue of influenza A virus from recombinant DNA. , 2007, Journal of virology.

[11]  I. Wilson,et al.  Structural basis of immune recognition of influenza virus hemagglutinin. , 1990, Annual review of immunology.

[12]  H. Lawson,et al.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[13]  S. Layne Human Influenza Surveillance: the Demand to Expand , 2006, Emerging infectious diseases.

[14]  N. Cox,et al.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[15]  W. Dowdle,et al.  Antigenic variation in current human type A influenza viruses: antigenic characteristics of the variants and their geographic distribution. , 1973, Bulletin of the World Health Organization.

[16]  Derek J. Smith,et al.  Applications of bioinformatics and computational biology to influenza surveillance and vaccine strain selection. , 2003, Vaccine.

[17]  G L Ada,et al.  Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). , 1997, Vaccine.

[18]  W. Fitch,et al.  Predicting the evolution of human influenza A. , 1999, Science.

[19]  E. D. Kilbourne Future influenza vaccines and the use of genetic recombinants. , 1969, Bulletin of the World Health Organization.

[20]  R. Walker,et al.  Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities. , 2003, Vaccine.

[21]  R. Webster,et al.  Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. , 1989, The Journal of infectious diseases.

[22]  D. T. Lee,et al.  Phylo-mLogo: an interactive and hierarchical multiple-logo visualization tool for alignment of many sequences , 2007, BMC Bioinformatics.

[23]  Min-Shi Lee,et al.  Predicting Antigenic Variants of Influenza A/H3N2 Viruses , 2004, Emerging infectious diseases.

[24]  R. Webster,et al.  Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective , 1995, Journal of virology.

[25]  Jonathan Dushoff,et al.  Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus , 2003, Proceedings of the National Academy of Sciences of the United States of America.